The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™)
Article first published online: 28 FEB 2012
Copyright © 2012 John Wiley & Sons, Ltd.
Drug Testing and Analysis
Volume 5, Issue 4, pages 247–253, April 2013
How to Cite
Kavanagh, P., Angelov, D., O'Brien, J., Power, J. D., McDermott, S. D., Talbot, B., Fox, J., O'Donnell, C. and Christie, R. (2013), The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™). Drug Test Analysis, 5: 247–253. doi: 10.1002/dta.411
- Issue published online: 22 APR 2013
- Article first published online: 28 FEB 2012
- Manuscript Revised: 7 DEC 2011
- Manuscript Accepted: 7 DEC 2011
- Manuscript Received: 17 NOV 2011
- mass spectrum
N-Methyl-3-phenyl-norbornan-2-amine (N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine, Camfetamine™) is available from a number of online legal highs/research chemicals' vendors. Although it was developed as an analeptic by Merck in the early 1960s, it was never commercialized. However, the Association of Independent Research Chemical Retailers (AIRCR), an umbrella organization for a number of online vendors, has redeveloped it for use as a recreational drug. N-Methyl-3-phenyl-norbornan-2-amine is closely related to fencamfamine which has been widely used as a central nervous system (CNS) stimulant and appetite suppressant. In this paper we describe the synthesis of N-methyl-3-phenyl-norbornan-2-amine, its characterization and interpretations of its electron impact, and electrospray ionization mass spectra. Copyright © 2012 John Wiley & Sons, Ltd.